Data / Form D filings / Starling Medical, Inc.
Starling Medical, Inc.: Form D filings
Starling Medical, Inc., a biotechnology company in Houston, TX, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on March 19, 2026, reports $824,990 sold of a $1.8 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2450 Holcombe Boulevard Suite 1320, Houston, TX, 77021
- Phone
- (888) 599-8927
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2031505
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | New notice | $1,750,000 | $824,990 | $925,010 | 5 | Feb 27, 2026 | sec.gov |
| Dec 9, 2024 | Amendment | $8,890,606 | $8,890,606 | 40 | Sep 6, 2024 | sec.gov | |
| Sep 18, 2024 | New notice | $7,300,613 | $6,750,611 | $550,002 | 37 | Sep 6, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Andrew Hendricks | Director | |
| Kunj Sheth | Director | |
| Shana Barghouti | Director | |
| Hannah McKenney | Executive Officer, Director | |
| William Hagaman | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Mar 16, 2026 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Starling Medical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.